Technology | March 19, 2013

Terumo Expands Radial-Specific Family of Heartrail III Coronary Guiding Catheters

A lower profile guiding catheter ideally suited for treating interventions in smaller stature patients

March 19, 2013 — Terumo Interventional Systems expanded its family of Heartrail III Coronary Guiding Catheters to include a smaller profile 5 French Ikari shape, specifically designed to provide backup support and access to target coronary lesions during transradial catheterizations.  The smaller 5 French Heartrail is designed to help physicians achieve access to the coronary arteries using a smaller-diameter catheter platform, and proprietary Ikari tip shapes, while providing the backup support and body of a traditionally larger French size catheter.

The smaller size enhances the Heartrail III guiding catheter portfolio by providing various options in response to guide catheter support needs during transradial catheterizations. Benefits include:

  • Proprietary outer surface treatment, to reduce friction between the catheter and inner lumen of the artery.
  • Flexible shaft design, for optimal trackability, even in tortuous vessels.
  • Efficient torque control, providing smooth handling and accurate engagement of the artery.
  • High radiopacity, for enhanced visibility that allows accurate tip positioning in the coronary ostium.
  • Bigger lumen size, to reduce device friction for ease of device manipulation.

Transradial catheterization is used to gain access to the heart through the arteries of the wrist, rather than the groin. It is the leading access strategy in many countries of the world and while the technique accounts for an estimated 15-20 percent of cases in the United States, there is a growing interest among physicians for more specialized tools that facilitate the procedure.

For more information: www.terumois.com


Related Content

News | Cath Lab

May 13, 2026 — According to a recently released report, the global cath lab services market was valued at $46.0 billion ...

Home May 13, 2026
Home
News | Cath Lab

April 16, 2026 — A national study led by investigators from Cedars-Sinai Health Sciences University found that ...

Home April 20, 2026
Home
News | Cath Lab

April 6, 2026 —Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its Synchrony system ...

Home April 07, 2026
Home
News | Cath Lab

March 31, 2026 — Solo Pace Inc. has announced the commercial release of the SoloPace Fusion Temporary Pacing System. The ...

Home April 03, 2026
Home
News | Cath Lab

March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is ...

Home March 26, 2026
Home
Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
Subscribe Now